Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: Results of a glucose-clamp study

Diabetes/Metabolism Research and Reviews

Volumn 21, Issue 5, 2005, Pages 459-464

  Rave, Klaus ^a   Flesch, Sabine ^a   Kühn Velten, W Nikolaus ^b   Hompesch, Beate C ^a   Heinemann, Lutz ^a   Heise, Tim ^a  

^a Profil Institute for Metabolic Research   (Germany)

^b Medizinisches Labor Bremen   (Germany)

Author keywords

ACE inhibitor; Drug interaction; Glucose clamp; Hypoglycemia; Insulin sensitivity; Sulfonylurea

Indexed keywords

C PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLIBENCLAMIDE; INSULIN; PLACEBO; SULFONYLUREA;

ADULT; ARTICLE; CLAMP; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENTIATION; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; HYPOGLYCEMIA; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD GLUCOSE; BLOOD PRESSURE; C-PEPTIDE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; ENALAPRIL; GLUCOSE CLAMP TECHNIQUE; GLYBURIDE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PLACEBOS; POTASSIUM;

EID: 24944551914     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.563     Document Type: Article

References (27)

1. Herings RM, de Boer A, Stricker BH, Leufkens HG, Porsius A. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet 1995; 345: 1195-1198.
2. Moore N, Kreft-Jais C, Haramburu F, et al. Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database. Br J Clin Pharmacol 1997; 44: 513-518.
3. Morris AD, Boyle DI, McMahon AD, et al. ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside, Scotland. Medicines Monitoring Unit. Diabetes Care 1997; 20: 1363-1367.
4. Thamer M, Ray NF, Taylor T. Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas. Clin Ther 1999; 21: 1387-1400.
5. Arauz-Pacheco C, Ramirez LC, Rios JM, Raskin P. Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy. Am J Med 1990; 89: 811-813.
6. Ahmad S. Drug interaction induces hypoglycemia. J Fam Pract 1995; 40: 540-541.
7. Buller GK, Perazella M. ACE inhibitor-induced hypoglycemia. Am J Med 1991; 91: 104-105.
8. Rett K, Wicklmayr M, Dietze GJ. Hypoglycemia in hypertensive diabetic patients treated with sulfonylureas, biguanides, and captopril. N Engl J Med 1988; 319: 1609.
9. Rett K, Lotz N, Wicklmayr M, et al. Verbesserte insulinwirkung durch ACE-hemmung beim typ-II-diabetiker. Dtsch Med Wochenschr 1988; 113: 243-249.
10. Torlone E, Rambotti AM, Perriello G, et al. ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension. Diabetologia 1991; 34: 119-125.
11. Torlone E, Britta M, Rambotti AM, et al. Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes. Diabetes Care 1993; 16: 1347-1355.
12. Vuorinen-Markkola H, Yki-Jarvinen H. Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus. Metabolism 1995; 44: 85-89.
13. Prince MJ, Stuart CA, Padia M, Bandi Z, Holland OB. Metabolic effects of hydrochlorothiazide and enalapril during treatment of the hypertensive diabetic patient. Enalapril for hypertensive diabetics. Arch Intern Med 1988; 148: 2363-2368.
14. Seghieri G, Yin W, Boni C, et al. Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients. Diabet Med 1992; 9: 732-738.
15. Seefeldt T, Orskov L, Mengel A, et al. Lack of effects of angiotensin-converting enzyme (ACE)-inhibitors on glucose metabolism in type 1 diabetes. Diabet Med 1990; 7: 700-704.
16. Starke AAR. Determination of insulin sensitivity: methodological considerations. J Cardiovasc Pharmacol 1992; 20: S17-S21.
17. Susanto F, Reinauer H. Glibenclamide in serum: comparison of high/performance liquid chromatography using fluorescence detector and liquid chromatography/mass spectrometry with atmospheric-pressure chemical ionization (APCI LC/MS). Fresenius J Anal Chem 1996; 356: 352-357.
18. Ampudia-Blasco FJ, Heinemann L, Bender R, et al. Comparative dose-related time-action profiles of glibenclamide and a new non-sulphonylurea drug, AG-EE 623 ZW, during euglycaemic clamp in healthy subjects. Diabetologia 1994; 37: 703-707.
19. Bender R, Heinemann L. Fitting nonlinear regression models with correlated errors to individual pharmacodynamic data using SAS software. J Pharmacokinet Biopharm 1995; 23: 87-100.
20. Ashcroft FM, Gribble FM. ATP-sensitive K+ channels and insulin secretion: their role in health and disease. Diabetologia 1999; 42: 903-919.
21. Rave K, Heise T, Weyer C, Sawicki P, Heinemann L. Measurement of insulin sensitivity: influence of potassium supply during euglycaemic glucose clamps in healthy volunteers. Exp Clin Endocrinol Diabetes 1999; 107: 313-317.
22. De Feo P, Torlone E, Perriello G, et al. Short-term metabolic effects of the ACE-inhibitor benazepril in type 2 diabetes mellitus associated with arterial hypertension. Diabet Metab 1992; 18: 283-288.
23. Monge L, Mojena M, Ortega JL, Samper B, Cabello MA, Feliu JE. Chlorpropamide raises fructose-2,6-bisphosphate concentration and inhibits gluconeogenesis in isolated rat hepatocytes. Diabetes 1986; 35: 89-96.
24. Uehara M, Kishikawa H, Isami S, et al. Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans. Diabetologia 1994; 37: 300-307.
25. Ventura HO, Frohlich ED, Messerli FH, Kobrin I, Kardon MB. Immediate regional blood flow distribution following angiotensin converting enzyme inhibition in patients with essential hypertension. Am J Med 1984; 76: 58-61.
26. McMurray J, Fraser DM. Captopril, enalapril, and blood glucose. Lancet 1986; 1: 1035.
27. Short RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997; 157: 1681-1686.